Xavier Matias-Guiu Guia
Grau: Doctor/a
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Grups
Publicacions
-
Delgado-Garcia, M; Weynand, B; Gomez-Izquierdo, L; Hernandez, MJ; Blanco, AM; Varela, M; Matias-Guiu, X; Nadal, E; Marquez-Lobo, B; Alarcão A; de Alava, E; Biscuola, M
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Bmc Cancer 20 275-275. .
-
Matias-Guiu, X; Stanta, G; Carneiro, F; Ryska, A; Hoefler, G; Moch, H; European Society of Pathology (ESP)
The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
VIRCHOWS ARCHIV 476 491-497. .
-
Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Zudaire, T; Guarch, R; Guerrero-Setas, D; Vidal, A; Santos-Salas, J; Matias-Guiu, X; Ausin, K; Díaz de Cerio MJ; Martin-Sanchez, E
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 -. .
-
Leon-Castillo, A; Gilvazquez, E; Nout, R; Smit, VTHBM; McAlpine, JN; McConechy, M; Kommoss, S; Brucker, SY; Carlson, JW; Epstein, E; Rau, TT; Soslow, RA; Ganesan, R; Matias-Guiu, X; Oliva, E; Harrison, BT; Church, DN; Gilks, CB; Bosse, T
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas
JOURNAL OF PATHOLOGY 250 312-322. .
-
Santiago-O'Farrill, JM; Weroha, SJ; Hou, XN; Oberg, AL; Heinzen, EP; Maurer, MJ; Pang, L; Rask, P; Amaravadi, RK; Becker, SE; Romero, I; Rubio, MJ; Matias-Guiu, X; Santacana, M; Llombart-Cussac, A; Poveda, A; Lu, Z; Bast, RC
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
CANCER 126 894-907. .
-
Cuevas, D; Velasco, A; Vaquero, M; Santacana, M; Gatius, S; Eritja, N; Estaran, E; Matias-Guiu, X
Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY.
Histopathology 76 447-460. .
-
Palacios J; de la Hoya M; Bellosillo B; de Juan I; Matías-Guiu X; Lázaro C; Palanca S; Osorio A; Rojo F; Rosa-Rosa JM; Cigudosa JC
Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).
VIRCHOWS ARCHIV 476 195-207. .
-
Cameselle-Teijeiro JM; Bella Cueto MR; Eloy C; Abdulkader I; Amendoeira I; Matías-Guiu X; Sobrinho-Simões M
Tumores de la glándula tiroides. Propuesta para el manejo y estudio de las muestras de pacientes con neoplasias tiroideas.
Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 27-36. .
-
Davidson, B; Matias-Guiu, X; Lax, SF
The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma.
VIRCHOWS ARCHIV 476 489-490. .
-
Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A
T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.
JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .
-
Etxeberria, I; Bolaños E; Quetglas, JI; Gros, A; Villanueva, A; Palomero, J; Sanchez-Paulete, AR; Piulats, JM; Matias-Guiu, X; Olivera, I; Ochoa, MC; Labiano, S; Garasa, S; Rodriguez, I; Vidal, A; Mancheño U; Hervas-Stubbs, S; Azpilikueta, A; Otano, I; Aznar, MA; Sanmamed, MF; Inoges, S; Berraondo, P; Teijeira, A; Melero, I
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8(+)T Cells
CANCER CELL 36 613-629. .
-
Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, CV; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J
Early evolutionary divergence between papillary and anaplastic thyroid cancers (vol 29, pg 1454, 2018)
ANNALS OF ONCOLOGY 30 1843-1843. .
Projectes
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
